Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension

1  Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois 60611-3008; and 2  Department of Pediatrics and 3  Cardiothoracic Surgery, University of California, San Francisco, California 94143-0106 Life-threatening increases in pulmonary vascular resistance have been noted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 1999-11, Vol.277 (5), p.H1849-H1856
Hauptverfasser: Black, Stephen M, Heidersbach, R. Scott, McMullan, D. Michael, Bekker, Janine M, Johengen, Michael J, Fineman, Jeffrey R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H1856
container_issue 5
container_start_page H1849
container_title American journal of physiology. Heart and circulatory physiology
container_volume 277
creator Black, Stephen M
Heidersbach, R. Scott
McMullan, D. Michael
Bekker, Janine M
Johengen, Michael J
Fineman, Jeffrey R
description 1  Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois 60611-3008; and 2  Department of Pediatrics and 3  Cardiothoracic Surgery, University of California, San Francisco, California 94143-0106 Life-threatening increases in pulmonary vascular resistance have been noted on acute withdrawal of inhaled nitric oxide (NO), although the mechanisms remain unknown. In vitro data suggest that exogenous NO exposure inhibits endothelial NO synthase (NOS) activity. Thus the objectives of this study were to determine the effects of inhaled NO therapy and its acute withdrawal on endogenous NOS activity and gene expression in vivo in the intact lamb. Six 1-mo-old lambs were mechanically ventilated and instrumented to measure vascular pressures and left pulmonary blood flow. Inhaled NO (40 ppm) acutely decreased left pulmonary vascular resistance by 27.5 ± 4.7% ( P  
doi_str_mv 10.1152/ajpheart.1999.277.5.h1849
format Article
fullrecord <record><control><sourceid>pubmed_highw</sourceid><recordid>TN_cdi_highwire_physiology_ajpheart_277_5_H1849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10564139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-f7ea83a79f8d49d921f2a58d4cf5407bfb89cdff990d386cf90870d22c9c44b23</originalsourceid><addsrcrecordid>eNp1kMlO9SAYhonR6HG4BYMX0AqltOV3ZYxTYnShrgllEPw7BThq715OjuPCFV_43ucNPAAcYZRjTItj8TxZLXzMMWMsL-o6p7nFTck2wCLtiwxTwjbBApGKZBUmdAfshvCMEKJ1RbbBDka0KjFhC_D_erCi0woOLnon4fjmlIZusK51McDbu3soZHQvLs7pFnaib8M_OI1RD9GJDvZaWjG40EMzeuh1Oy4HBadl14-D8DO086R9Cgc3Dvtgy4gu6IOPcw88Xpw_nF1lN3eX12enN5ksaxwzU2vREFEz06iSKVZgUwiaZmloierWtA2TyhjGkCJNJQ1DTY1UUUgmy7ItyB5g617pxxC8Nnzyrk-v4RjxlUD-KZCvBPIkkFN-tRKY2MM1Oy3bXqsf5NpYChyvA9Y92VfnNZ_snH7XjU_zd-_vypO_iYtl1z3ot_iF_iD5pAx5B_vfmQM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Black, Stephen M ; Heidersbach, R. Scott ; McMullan, D. Michael ; Bekker, Janine M ; Johengen, Michael J ; Fineman, Jeffrey R</creator><creatorcontrib>Black, Stephen M ; Heidersbach, R. Scott ; McMullan, D. Michael ; Bekker, Janine M ; Johengen, Michael J ; Fineman, Jeffrey R</creatorcontrib><description>1  Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois 60611-3008; and 2  Department of Pediatrics and 3  Cardiothoracic Surgery, University of California, San Francisco, California 94143-0106 Life-threatening increases in pulmonary vascular resistance have been noted on acute withdrawal of inhaled nitric oxide (NO), although the mechanisms remain unknown. In vitro data suggest that exogenous NO exposure inhibits endothelial NO synthase (NOS) activity. Thus the objectives of this study were to determine the effects of inhaled NO therapy and its acute withdrawal on endogenous NOS activity and gene expression in vivo in the intact lamb. Six 1-mo-old lambs were mechanically ventilated and instrumented to measure vascular pressures and left pulmonary blood flow. Inhaled NO (40 ppm) acutely decreased left pulmonary vascular resistance by 27.5 ± 4.7% ( P  &lt; 0.05). This was associated with a 207% increase in plasma cGMP concentrations ( P  &lt; 0.05). After 6 h of inhaled NO, NOS activity was reduced to 44.3 ± 5.9% of pre-NO values ( P   &lt; 0.05). After acute withdrawal of NO, pulmonary vascular resistance increased by 52.1 ± 11.6% ( P  &lt; 0.05) and cGMP concentrations decreased. Both returned to pre-NO values within 60 min. One hour after NO withdrawal, NOS activity increased by 48.4 ± 19.1% to 70% of pre-NO values ( P  &lt; 0.05). Western blot analysis revealed that endothelial NOS protein levels remained unchanged throughout the study period. These data suggest a role for decreased endogenous NOS activity in the rebound pulmonary hypertension noted after acute withdrawal of inhaled NO. endothelium-derived factors; pulmonary heart disease</description><identifier>ISSN: 0363-6135</identifier><identifier>ISSN: 0002-9513</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.1999.277.5.h1849</identifier><identifier>PMID: 10564139</identifier><language>eng</language><publisher>United States</publisher><subject>Administration, Inhalation ; Animals ; Cyclic GMP - blood ; Endothelium, Vascular - enzymology ; Enzyme Inhibitors - administration &amp; dosage ; Enzyme Inhibitors - adverse effects ; Enzyme Inhibitors - pharmacology ; Gene Expression - drug effects ; Hypertension, Pulmonary - chemically induced ; Nitric Oxide - administration &amp; dosage ; Nitric Oxide - adverse effects ; Nitric Oxide - pharmacology ; Nitric Oxide Synthase - antagonists &amp; inhibitors ; Nitric Oxide Synthase - genetics ; Nitric Oxide Synthase - metabolism ; Pulmonary Circulation - drug effects ; Sheep ; Substance Withdrawal Syndrome ; Time Factors ; Vascular Resistance - drug effects</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 1999-11, Vol.277 (5), p.H1849-H1856</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-f7ea83a79f8d49d921f2a58d4cf5407bfb89cdff990d386cf90870d22c9c44b23</citedby><cites>FETCH-LOGICAL-c471t-f7ea83a79f8d49d921f2a58d4cf5407bfb89cdff990d386cf90870d22c9c44b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,3026,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10564139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Black, Stephen M</creatorcontrib><creatorcontrib>Heidersbach, R. Scott</creatorcontrib><creatorcontrib>McMullan, D. Michael</creatorcontrib><creatorcontrib>Bekker, Janine M</creatorcontrib><creatorcontrib>Johengen, Michael J</creatorcontrib><creatorcontrib>Fineman, Jeffrey R</creatorcontrib><title>Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol</addtitle><description>1  Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois 60611-3008; and 2  Department of Pediatrics and 3  Cardiothoracic Surgery, University of California, San Francisco, California 94143-0106 Life-threatening increases in pulmonary vascular resistance have been noted on acute withdrawal of inhaled nitric oxide (NO), although the mechanisms remain unknown. In vitro data suggest that exogenous NO exposure inhibits endothelial NO synthase (NOS) activity. Thus the objectives of this study were to determine the effects of inhaled NO therapy and its acute withdrawal on endogenous NOS activity and gene expression in vivo in the intact lamb. Six 1-mo-old lambs were mechanically ventilated and instrumented to measure vascular pressures and left pulmonary blood flow. Inhaled NO (40 ppm) acutely decreased left pulmonary vascular resistance by 27.5 ± 4.7% ( P  &lt; 0.05). This was associated with a 207% increase in plasma cGMP concentrations ( P  &lt; 0.05). After 6 h of inhaled NO, NOS activity was reduced to 44.3 ± 5.9% of pre-NO values ( P   &lt; 0.05). After acute withdrawal of NO, pulmonary vascular resistance increased by 52.1 ± 11.6% ( P  &lt; 0.05) and cGMP concentrations decreased. Both returned to pre-NO values within 60 min. One hour after NO withdrawal, NOS activity increased by 48.4 ± 19.1% to 70% of pre-NO values ( P  &lt; 0.05). Western blot analysis revealed that endothelial NOS protein levels remained unchanged throughout the study period. These data suggest a role for decreased endogenous NOS activity in the rebound pulmonary hypertension noted after acute withdrawal of inhaled NO. endothelium-derived factors; pulmonary heart disease</description><subject>Administration, Inhalation</subject><subject>Animals</subject><subject>Cyclic GMP - blood</subject><subject>Endothelium, Vascular - enzymology</subject><subject>Enzyme Inhibitors - administration &amp; dosage</subject><subject>Enzyme Inhibitors - adverse effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene Expression - drug effects</subject><subject>Hypertension, Pulmonary - chemically induced</subject><subject>Nitric Oxide - administration &amp; dosage</subject><subject>Nitric Oxide - adverse effects</subject><subject>Nitric Oxide - pharmacology</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase - genetics</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Pulmonary Circulation - drug effects</subject><subject>Sheep</subject><subject>Substance Withdrawal Syndrome</subject><subject>Time Factors</subject><subject>Vascular Resistance - drug effects</subject><issn>0363-6135</issn><issn>0002-9513</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMlO9SAYhonR6HG4BYMX0AqltOV3ZYxTYnShrgllEPw7BThq715OjuPCFV_43ucNPAAcYZRjTItj8TxZLXzMMWMsL-o6p7nFTck2wCLtiwxTwjbBApGKZBUmdAfshvCMEKJ1RbbBDka0KjFhC_D_erCi0woOLnon4fjmlIZusK51McDbu3soZHQvLs7pFnaib8M_OI1RD9GJDvZaWjG40EMzeuh1Oy4HBadl14-D8DO086R9Cgc3Dvtgy4gu6IOPcw88Xpw_nF1lN3eX12enN5ksaxwzU2vREFEz06iSKVZgUwiaZmloierWtA2TyhjGkCJNJQ1DTY1UUUgmy7ItyB5g617pxxC8Nnzyrk-v4RjxlUD-KZCvBPIkkFN-tRKY2MM1Oy3bXqsf5NpYChyvA9Y92VfnNZ_snH7XjU_zd-_vypO_iYtl1z3ot_iF_iD5pAx5B_vfmQM</recordid><startdate>19991101</startdate><enddate>19991101</enddate><creator>Black, Stephen M</creator><creator>Heidersbach, R. Scott</creator><creator>McMullan, D. Michael</creator><creator>Bekker, Janine M</creator><creator>Johengen, Michael J</creator><creator>Fineman, Jeffrey R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19991101</creationdate><title>Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension</title><author>Black, Stephen M ; Heidersbach, R. Scott ; McMullan, D. Michael ; Bekker, Janine M ; Johengen, Michael J ; Fineman, Jeffrey R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-f7ea83a79f8d49d921f2a58d4cf5407bfb89cdff990d386cf90870d22c9c44b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Administration, Inhalation</topic><topic>Animals</topic><topic>Cyclic GMP - blood</topic><topic>Endothelium, Vascular - enzymology</topic><topic>Enzyme Inhibitors - administration &amp; dosage</topic><topic>Enzyme Inhibitors - adverse effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene Expression - drug effects</topic><topic>Hypertension, Pulmonary - chemically induced</topic><topic>Nitric Oxide - administration &amp; dosage</topic><topic>Nitric Oxide - adverse effects</topic><topic>Nitric Oxide - pharmacology</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase - genetics</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Pulmonary Circulation - drug effects</topic><topic>Sheep</topic><topic>Substance Withdrawal Syndrome</topic><topic>Time Factors</topic><topic>Vascular Resistance - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Black, Stephen M</creatorcontrib><creatorcontrib>Heidersbach, R. Scott</creatorcontrib><creatorcontrib>McMullan, D. Michael</creatorcontrib><creatorcontrib>Bekker, Janine M</creatorcontrib><creatorcontrib>Johengen, Michael J</creatorcontrib><creatorcontrib>Fineman, Jeffrey R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Black, Stephen M</au><au>Heidersbach, R. Scott</au><au>McMullan, D. Michael</au><au>Bekker, Janine M</au><au>Johengen, Michael J</au><au>Fineman, Jeffrey R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol</addtitle><date>1999-11-01</date><risdate>1999</risdate><volume>277</volume><issue>5</issue><spage>H1849</spage><epage>H1856</epage><pages>H1849-H1856</pages><issn>0363-6135</issn><issn>0002-9513</issn><eissn>1522-1539</eissn><abstract>1  Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois 60611-3008; and 2  Department of Pediatrics and 3  Cardiothoracic Surgery, University of California, San Francisco, California 94143-0106 Life-threatening increases in pulmonary vascular resistance have been noted on acute withdrawal of inhaled nitric oxide (NO), although the mechanisms remain unknown. In vitro data suggest that exogenous NO exposure inhibits endothelial NO synthase (NOS) activity. Thus the objectives of this study were to determine the effects of inhaled NO therapy and its acute withdrawal on endogenous NOS activity and gene expression in vivo in the intact lamb. Six 1-mo-old lambs were mechanically ventilated and instrumented to measure vascular pressures and left pulmonary blood flow. Inhaled NO (40 ppm) acutely decreased left pulmonary vascular resistance by 27.5 ± 4.7% ( P  &lt; 0.05). This was associated with a 207% increase in plasma cGMP concentrations ( P  &lt; 0.05). After 6 h of inhaled NO, NOS activity was reduced to 44.3 ± 5.9% of pre-NO values ( P   &lt; 0.05). After acute withdrawal of NO, pulmonary vascular resistance increased by 52.1 ± 11.6% ( P  &lt; 0.05) and cGMP concentrations decreased. Both returned to pre-NO values within 60 min. One hour after NO withdrawal, NOS activity increased by 48.4 ± 19.1% to 70% of pre-NO values ( P  &lt; 0.05). Western blot analysis revealed that endothelial NOS protein levels remained unchanged throughout the study period. These data suggest a role for decreased endogenous NOS activity in the rebound pulmonary hypertension noted after acute withdrawal of inhaled NO. endothelium-derived factors; pulmonary heart disease</abstract><cop>United States</cop><pmid>10564139</pmid><doi>10.1152/ajpheart.1999.277.5.h1849</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 1999-11, Vol.277 (5), p.H1849-H1856
issn 0363-6135
0002-9513
1522-1539
language eng
recordid cdi_highwire_physiology_ajpheart_277_5_H1849
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Administration, Inhalation
Animals
Cyclic GMP - blood
Endothelium, Vascular - enzymology
Enzyme Inhibitors - administration & dosage
Enzyme Inhibitors - adverse effects
Enzyme Inhibitors - pharmacology
Gene Expression - drug effects
Hypertension, Pulmonary - chemically induced
Nitric Oxide - administration & dosage
Nitric Oxide - adverse effects
Nitric Oxide - pharmacology
Nitric Oxide Synthase - antagonists & inhibitors
Nitric Oxide Synthase - genetics
Nitric Oxide Synthase - metabolism
Pulmonary Circulation - drug effects
Sheep
Substance Withdrawal Syndrome
Time Factors
Vascular Resistance - drug effects
title Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A19%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhaled%20nitric%20oxide%20inhibits%20NOS%20activity%20in%20lambs:%20potential%20mechanism%20for%20rebound%20pulmonary%20hypertension&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Black,%20Stephen%20M&rft.date=1999-11-01&rft.volume=277&rft.issue=5&rft.spage=H1849&rft.epage=H1856&rft.pages=H1849-H1856&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.1999.277.5.h1849&rft_dat=%3Cpubmed_highw%3E10564139%3C/pubmed_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10564139&rfr_iscdi=true